pioneer plus semaglutide Efficacy and safety of once-daily oral 25 mg and 50 mg compared with 14 mg in adults with type 2 diabetes (PIONEER PLUS): a multicentre, randomised, phase 3b trial ADA Clinical Trial Talks: Oral

DISCUSSION As previously shown, plasma ALCAR levels are decreased in patients with ATN [14,20]

Thus, these results suggest that liraglutide could reduce, at least in part, the secretion of pro-inflammatory cytokines in OA synovium by stimulating macrophages and polarization toward an M2 anti-inflammatory phenotype, leading to a decrease in OA-induced joint destruction

However, excessive activation of ATF4 in PD models is pathologically associated with progressive loss of dopaminergic neurons in the substantia nigra

Human stem cell modeling in neurofibromatosis type 1 (NF1)

Novel MED12 gene somatic mutations in women from the Southern United States with symptomatic uterine fibroids